Inventor
ELDRUP ANNE B
US17 patents
⚠️ This page may combine multiple inventors who share the name “ELDRUP ANNE B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ISIS PHARMACEUTICALS INC
4 patentsUS7105499B2Sep 12, 2006
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
ISIS PHARMACEUTICALS INC233 citations99
US7202224B2Apr 10, 2007
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
ISIS PHARMACEUTICALS INC222 citations98
US7919612B2Apr 5, 2011
2′-substituted oligomeric compounds and compositions for use in gene modulations
ISIS PHARMACEUTICALS INC14 citations92
US7812149B2Oct 12, 2010
2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
ISIS PHARMACEUTICALS INC12 citations84
MERCK & CO INC
4 patentsUS7534767B2May 19, 2009
C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymerase
MERCK & CO INC69 citations98
US7125855B2Oct 24, 2006
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
MERCK & CO INC301 citations98
US6777395B2Aug 17, 2004
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus
MERCK & CO INC356 citations98
US7323453B2Jan 29, 2008
Methods of inhibiting orthopoxvirus replication with nucleoside compounds
MERCK & CO INC71 citations97
ALLERSON CHARLES
3 patentsUS8604183B2Dec 10, 2013
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
ALLERSON CHARLES20 citations92
US9150606B2Oct 6, 2015
Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
ALLERSON CHARLES9 citations84
US9150605B2Oct 6, 2015
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
ALLERSON CHARLES9 citations84
IONIS PHARMACEUTICALS INC
3 patentsUS10266825B2Apr 23, 2019
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
IONIS PHARMACEUTICALS INC10 citations84
US11078485B2Aug 3, 2021
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
IONIS PHARMACEUTICALS INC0 citations62
US9771578B2Sep 26, 2017
Phosphorous-linked oligomeric compounds and their use in gene modulation
IONIS PHARMACEUTICALS INC0 citations52